Fox Run Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-384
Closed -$148K 971
2022
Q4
$148K Buy
+384
New +$148K 0.06% 525
2022
Q2
Sell
-304
Closed -$133K 780
2022
Q1
$133K Buy
+304
New +$133K 0.07% 446
2018
Q1
Sell
-356
Closed -$157K 965
2017
Q4
$157K Buy
+356
New +$157K 0.05% 608